Earnings Call Summary | Health Catalyst(HCAT.US) Q1 2024 Earnings Conference
Earnings Call Summary | Health Catalyst(HCAT.US) Q1 2024 Earnings Conference
The following is a summary of the Health Catalyst, Inc. (HCAT) Q1 2024 Earnings Call Transcript:
以下是健康催化劑公司（HCAT）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Health Catalyst reported Q1 2024 total revenue of $74.7 million, and adjusted EBITDA of $3.4 million.
The company's adjusted gross margin was 68% for technology and 22% for professional services.
The company ended Q1 2024 with $327.8 million in cash, cash equivalents, and short-term investments.
The company reported a strong Q1 that was in line with expectations, and expects to generate $300 million in revenue in 2024.
Health Catalyst報告稱，2024年第一季度總收入爲7,470萬美元，調整後的息稅折舊攤銷前利潤爲340萬美元。
該公司調整後的技術毛利率爲68％，專業服務毛利率爲22％。
截至2024年第一季度，該公司擁有3.278億美元的現金、現金等價物和短期投資。
該公司報告稱，第一季度表現強勁，符合預期，預計2024年將創造3億美元的收入。
Business Progress:
業務進展：
The company's growth strategy includes expanding existing client relationships and beginning new client relationships with strong demand reported for its new Health Catalyst Ignite platform.
The company expanded its relationship with Saudi German Health, resulting in a meaningful technology expansion in the international segment.
Health Catalyst is considering potential acquisitions in the application layer or tech enablement while maintaining disciplined capital allocation.
Despite challenges such as the bankruptcy proceedings of Steward Health Care, the company remains optimistic about its strategic partnerships.
The company reported a positive trend of improved client retention, which impacts growth positively by supporting a growing client base, aided by its tech-enabled managed services offering.
Health Catalyst expects to see around a 10-point improvement in technology gross margin over the next 2-3 years as they transition most of their existing clients onto their more efficient and scalable Ignite platform.
該公司的增長戰略包括擴大現有的客戶關係和開始新的客戶關係，據報道，其新的Health Catalyst Ignite平台需求強勁。
該公司擴大了與沙特德國健康的關係，從而在國際領域進行了有意義的技術擴張。
Health Catalyst正在考慮在應用層或技術支持方面進行潛在的收購，同時保持嚴格的資本配置。
儘管面臨諸如Steward Health Care破產程序之類的挑戰，但該公司仍對其戰略合作伙伴關係持樂觀態度。
該公司報告了客戶保留率提高的積極趨勢，通過支持不斷增長的客戶群，再加上其以技術爲支撐的託管服務，這對增長產生了積極影響。
Health Catalyst預計，隨着大多數現有客戶過渡到更高效、更具可擴展性的Ignite平台，未來2-3年技術毛利率將提高約10個百分點。
More details: Health Catalyst IR
更多詳情： 健康催化劑 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。